Baxalta is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division. The company began its operation with a revenue of $6 billion, and is now a subsidiary of Takeda Pharmaceutical Company. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Baxalta (United States), United States, covering academic research published from 2001 to 2024. Read More.
Open Access Percentage
51%
Total
Publications
301
Total Open
Publications
154
Total
Citations
6.5K
Open Access
Percentage
51%
Total
Publications
301
Total Open
Publications
154
Total
Citations
6.5K
Breakdown
Publisher Open
30%
Both
18%
Other Platform Open
2%
Closed
50%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 15%
21
Hybrid 56%
79
No Guarantees 29%
41
Other Platform Open
Domain 77%
44
Institution 28%
16
Other Internet 23%
13
Public 2%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 45 |
DOI | Other Internet | 10 |
Library Stack - Library Stack | Institution | 7 |
California Digital Library - eScholarship | Institution | 7 |
Unknown Repository | Other Internet | 3 |
São Paulo State University - UNESP Institutional Repository | Institution | 2 |
DANS - Data Archiving and Networked Services | Institution | 2 |
Utrecht University - Utrecht University Repository | Institution | 1 |
University of Michigan - Deep Blue | Institution | 1 |
University of Leeds, The University of Sheffield, University of York - White Rose Research Online | Institution | 1 |